Postoperative psychological symptoms (anxiety, depression, stress, and sleep).
Conditions
Interventions
Ropivacaine paravertebral nerve block:Ropivacaine paravertebral nerve block
Bupivacaine liposomal paravertebral nerve block group:Bupivacaine liposomal paravertebral nerve block
Sponsors
Qingdao Municipal Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.50 years old< age < 80 years old; ASAI.-III; 2.There is no limit to men and women; 3.Patients undergoing thoracoscopic surgery were selected; 4.Before the trial, understand the nature, significance, possible benefits, possible inconveniences and potential dangers of the trial, understand the study procedures, and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women and those who have a birth plan within 3 months; 2.Those with obvious respiratory and circulatory dysfunction, blood routine and blood biochemical indicators before surgery; 3.Those with severe neuropsychiatric diseases; 4.Allergic or contraindicated to drugs such as bupivacaine liposomes and their components; 5.Taking antidepressants, anxiolytics or other psychotropic drugs for a long time (more than 3 months); 6.Unable to understand or refuse to complete the questionnaire; 7. Patients who cannot obtain informed consent, or who are considered by the investigator to be inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the patient's postoperative psychological symptoms (anxiety, depression, stress and sleep).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients had a daily equivalent dose of morphine, an opioid analgesic, for 3 days postoperatively;Length of patient hospital stay;Pain scores (NRS) at rest and during coughing for patients 3 days postoperatively; | — |
Countries
China
Contacts
Public ContactWang Bin
Qingdao Municipal Hospital
Outcome results
None listed